See more : Frasers Logistics & Commercial Trust (FRLOF) Income Statement Analysis – Financial Results
Complete financial analysis of Brilliant Acquisition Corporation (BRLI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Brilliant Acquisition Corporation, a leading company in the Shell Companies industry within the Financial Services sector.
You may be interested
- Beijing Shuzhi Technology Co.,Ltd (300038.SZ) Income Statement Analysis – Financial Results
- Tekfen Holding Anonim Sirketi (TKFEN.IS) Income Statement Analysis – Financial Results
- Zehnder Group AG (ZEHN.SW) Income Statement Analysis – Financial Results
- ChitogenX Inc. (CHNXF) Income Statement Analysis – Financial Results
- Elis SA (ELSSF) Income Statement Analysis – Financial Results
Brilliant Acquisition Corporation (BRLI)
Industry: Shell Companies
Sector: Financial Services
About Brilliant Acquisition Corporation
Brilliant Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2019 and is based in Shanghai, China.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.20M | 670.92K | 148.01K | 0.00 |
| Gross Profit | -1.20M | -670.92K | -148.01K | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.20K | 670.92 | 148.01 | 35.42 |
| Other Expenses | 1.20M | 670.92K | 148.01K | 0.00 |
| Operating Expenses | 1.20M | 670.92K | 148.01K | 35.42 |
| Cost & Expenses | 1.20M | 670.92K | 148.01K | 35.42 |
| Interest Income | 64.95K | 4.63K | 3.06K | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | -169.84K | -67.16K | 172.79K | 171.86K |
| EBITDA | -1.37M | -670.92K | 24.78K | 0.00 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.20M | -670.92K | -148.01K | -35.42 |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 234.79K | 71.79K | -169.73K | 0.00 |
| Income Before Tax | -967.61K | -599.13K | -317.74K | -35.42 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -234.79K | -4.63K | -3.06K | 0.00 |
| Net Income | -732.83K | -594.49K | -314.68K | -35.42 |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.16 | -0.10 | -0.09 | 0.00 |
| EPS Diluted | -0.16 | -0.10 | -0.09 | 0.00 |
| Weighted Avg Shares Out | 4.64M | 6.11M | 3.70M | 0.00 |
| Weighted Avg Shares Out (Dil) | 4.64M | 6.11M | 3.70M | 0.00 |
Nukkleus Signs Term Sheet for Acquisition of Leading Cross Border Payments Firm Mercury Global
NEW YORK--(BUSINESS WIRE)---- $BRLI #Fintech--Nukkleus Inc. (NASDAQ: NUKK), a pioneering force in the fintech industry, is excited to announce that it has signed a term sheet for the acquisition of Mercury Global, a leading cross-border payments firm with operations in...
Nukkleus, Inc. Finalizes Transformative Merger with Brilliant Acquisition Corp, Unveiling New Horizons in Digital Asset Solutions for Customers
NEW YORK , Nov. 30, 2023 /PRNewswire/ -- Nukkleus, Inc. (formerly Compliance & Risk Management Solutions Inc.) (OTC: NUKK) proudly announces the completion of its strategic merger with Brilliant Acquisition Corp (Nasdaq: BRLI), marking a significant milestone in the financial...
Brilliant Acquisition Corporation Announces Extension of Completion Window to December 23, 2023
New York, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation (“Brilliant”) announced today that it has extended the period of time it will have to consummate its initial business combination by a further one month, or until December 23,...
Brilliant Acquisition Corporation Announces Extension of Completion Window to October 23, 2023
New York, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation (“Brilliant”) announced today that it has extended the period of time it will have to consummate its initial business combination by a further one month, or until October 23,...
Brilliant Acquisition Corporation Announces Extension of Completion Window to September 23, 2023
New York, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation (“Brilliant”) announced today that it has extended the period of time it will have to consummate its initial business combination by a further one month, or until September 23,...
Brilliant Acquisition Corporation Announces Extension of Completion Window to August 23, 2023
New York, July 21, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation (“Brilliant”) announced today that it has extended the period of time it will have to consummate its initial business combination by a further one month, or until August 23,...
Nukkleus Rebrands as Blockchain and Digital Payments Company
Nukkleus, which works on acquiring and scaling high-potential blockchain, digital and multi-asset businesses for retail and institutional markets, has debuted its new website and brand, which will put the firm's subsidiary brands under the same suite of assets, a press...
Opko Health's (OPK) "Buy" Rating Reiterated at Piper Sandler
Opko Health (NASDAQ:OPK)‘s stock had its “buy” rating reissued by equities research analysts at Piper Sandler in a research report issued to clients and investors on Wednesday, TipRanks reports. They presently have a $3.00 target price on the biotechnology company’s...
Big commercial labs given priority for coronavirus testing equipment by feds
Hospitals, clinics and point-of care medical centers across the country continue to grapple with critical shortages in testing supplies, more than a dozen lab personnel, state officials and medical associations say
Opko Health Inc. (NASDAQ:OPK) Receives Consensus Recommendation of "Buy" from Analysts
Opko Health Inc. (NASDAQ:OPK) has been given a consensus rating of “Buy” by the six brokerages that are presently covering the company, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating. The average 12 month...
Source: https://incomestatements.info
Category: Stock Reports